|
 |
|
CANCER |
|
|
Cancer kills
millions of people a year of all ages. More than half of all
malignant cancers disable patients during their most productive
years. The Baxter Oncology patients consist its of cytotoxic
therapies that treat a variety of cancer types as well as cell
selection, storage, washing and expansion products that are
primarily targeted to stem cell transplant centers. Leading the
portfolio of cancer therapies are HOLOXAN (ifosfmide) UROMITEXAN (mesna)
and ENDOXAN (cyclophosphamide).
|
|
BLOOD DISORDERS |
|
 |
Hemophilia is
one of a number if inherited bleeding disorders characterized by
an abnormality in the blood’s ability to clot. There is no cure,
but many people with hemophilia can lead productive lives with
regular infusions of clotting factor, Baxter is a leading
manufacturer of both genetically engineered (recombinant) and
plasma – based clotting factors. The company also manufactures
other therapeutic proteins for people with immune deficiencies
and other blood related disorders. |
|
|
|
|
TRAUMA |
|
|
Injury or
trauma is the leading cause of death for people under 44. Many
trauma victims receive Baxter products – IV solutions plasma
volume expanders, blood transfusion products, and other products
for fluid replenishment and blood volume stabilization.
|
|
| |
|
SURGICAL
INTERVENTION |
|
|
Baxter
products are used in a variety of surgical applications. Most
people undergoing surgery require IV access for solutions and
medicines. Precise infusion requires sophisticated electronic
infusion pumps to regulate flow. Baxter provides a broad range
of agents and delivery devices of general anesthesia. The
company manufactures fibrin sealant to facilitate blood clotting
and wound healing in surgery. Baxter blood – collection and
storage containers are used by blood banks to provide blood and
its components to hospitals and surgery centers for
transfusions. The company also manufactures ambulatory IV
infusion pumps used for patient controlled pain management.
|
|
| |
|
INFECTIOUS
DISEASES |
|
 |
Infectious
diseases continue to cause illness and death around the world.
While some infectious diseases have been conquered in some
geography through modern advances in antibiotics and vaccines,
new threats are constantly emerging. Lyme diseases, AIDS and new
strains of influenza like SARS are all diseases that have
emerged within the last 20 years. Baxter manufactures TICOVAX
the leading new generation vaccine for tick – borne encephalitis
(TBE), NeisVac for meningococcal diseases, both potentially
fatal illness and Accomb 2000 a prophylactic vaccine that guards
against smallpox. Baxter’s Gemmagard SD is being evaluated as
first line treatment against SARS. |
|
| |
|
KIDNEY DISEASES |
|
 |
Kidney
diseases continue to be a growing cause of illness and death
around the world. Patients with end – stage renal disease (ESRD),
or kidney failure, require dialysis or a kidney transplant to
cleanse their blood of toxins, waster and excess water normally
removed by healthy kidneys. Baxter was a pioneer in dialysis and
remains the world’s leading provider of products for peritoneal
dialysis. |
|
| |
| |
| |
